Accounts Receivable are created when a customer has received a product but has not yet paid for that product. DocMorris AG's accounts receivables for the quarter that ended in Jun. 2025 was CHF51 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
DocMorris AG's Days Sales Outstanding for the quarter that ended in Jun. 2025 was 17.16.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. DocMorris AG's Net-Net Working Capital per share for the quarter that ended in Jun. 2025 was CHF-2.85.
DocMorris AG Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
DocMorris AG's Days Sales Outstanding for the quarter that ended in Jun. 2025 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), DocMorris AG's accounts receivable are only considered to be worth 75% of book value:
DocMorris AG's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
DocMorris AG Accounts Receivable Related Terms
DocMorris AG Accounts Receivable Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Accounts Receivable of CHF51 Mil mean?
DocMorris AG (XSWX:DOCM) has a Accounts Receivable of CHF51 Mil as of Jun. 2025. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on DocMorris AG and its competitors.
Is DocMorris AG's Accounts Receivable too high?
DocMorris AG's current Accounts Receivable is CHF51 Mil. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Accounts Receivable compare to competitors?
DocMorris AG's Accounts Receivable of CHF51 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on DocMorris AG and its competitors. DocMorris AG's current Accounts Receivable is CHF51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.56, compared to a current price of CHF9.25 — trading 12.4% below its estimated fair value. The current Accounts Receivable is CHF51 Mil. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Accounts Receivable is CHF51 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF9.25 is trading 12.4% below its estimated GF Value™ of CHF10.56.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
Accounts Receivable: CHF51 Mil
GF Value™: CHF10.56 vs. price of CHF9.25 (12.4% below fair value)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
